把手
发表于 2025-3-26 23:22:50
Jürgen Faißt number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef
calamity
发表于 2025-3-27 03:52:30
http://reply.papertrans.cn/43/4262/426170/426170_32.png
远足
发表于 2025-3-27 05:16:33
http://reply.papertrans.cn/43/4262/426170/426170_33.png
Ataxia
发表于 2025-3-27 11:30:05
http://reply.papertrans.cn/43/4262/426170/426170_34.png
Offensive
发表于 2025-3-27 16:45:20
Jürgen Faißt number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef
消息灵通
发表于 2025-3-27 19:24:33
number of protocols.With both new and well established techAntibodies are indispensable tools for research, diagnosis, and therapy. Recombinant approaches allow the modification and improvement of nearly all antibody properties, such as affinity, valency, specificity, stability, serum half-life, ef
Acumen
发表于 2025-3-27 23:06:20
http://reply.papertrans.cn/43/4262/426170/426170_37.png
假设
发表于 2025-3-28 03:33:58
http://reply.papertrans.cn/43/4262/426170/426170_38.png
护身符
发表于 2025-3-28 08:30:15
http://reply.papertrans.cn/43/4262/426170/426170_39.png
弯腰
发表于 2025-3-28 12:20:16
http://reply.papertrans.cn/43/4262/426170/426170_40.png